200 related articles for article (PubMed ID: 32956692)
41. The EWS/FLI1 oncogenic protein inhibits expression of the Wnt inhibitor DICKKOPF-1 gene and antagonizes beta-catenin/TCF-mediated transcription.
Navarro D; Agra N; Pestaña A; Alonso J; González-Sancho JM
Carcinogenesis; 2010 Mar; 31(3):394-401. PubMed ID: 20019092
[TBL] [Abstract][Full Text] [Related]
42. Discovery of small molecule inhibitors of the Wnt/β-catenin signaling pathway by targeting β-catenin/Tcf4 interactions.
Yan M; Li G; An J
Exp Biol Med (Maywood); 2017 Jun; 242(11):1185-1197. PubMed ID: 28474989
[TBL] [Abstract][Full Text] [Related]
43. Homeobox protein MSX-1 inhibits expression of bone morphogenetic protein 2, bone morphogenetic protein 4, and lymphoid enhancer-binding factor 1 via Wnt/β-catenin signaling to prevent differentiation of dental mesenchymal cells during the late bell stage.
Feng XY; Wu XS; Wang JS; Zhang CM; Wang SL
Eur J Oral Sci; 2018 Feb; 126(1):1-12. PubMed ID: 29148101
[TBL] [Abstract][Full Text] [Related]
44. Hepatocyte growth factor activates Wnt pathway by transcriptional activation of LEF1 to facilitate tumor invasion.
Huang FI; Chen YL; Chang CN; Yuan RH; Jeng YM
Carcinogenesis; 2012 Jun; 33(6):1142-8. PubMed ID: 22436613
[TBL] [Abstract][Full Text] [Related]
45. Insights into PARP Inhibitors' Selectivity Using Fluorescence Polarization and Surface Plasmon Resonance Binding Assays.
Papeo G; Avanzi N; Bettoni S; Leone A; Paolucci M; Perego R; Quartieri F; Riccardi-Sirtori F; Thieffine S; Montagnoli A; Lupi R
J Biomol Screen; 2014 Sep; 19(8):1212-9. PubMed ID: 24916412
[TBL] [Abstract][Full Text] [Related]
46. Interferon Consensus Sequence-Binding Protein 8, a Tumor Suppressor, Suppresses Tumor Growth and Invasion of Non-Small Cell Lung Cancer by Interacting with the Wnt/β-Catenin Pathway.
Ye L; Xiang T; Zhu J; Li D; Shao Q; Peng W; Tang J; Li L; Ren G
Cell Physiol Biochem; 2018; 51(2):961-978. PubMed ID: 30466106
[TBL] [Abstract][Full Text] [Related]
47. Construction and application of a lung cancer stem cell model: antitumor drug screening and molecular mechanism of the inhibitory effects of sanguinarine.
Yang J; Fang Z; Wu J; Yin X; Fang Y; Zhao F; Zhu S; Li Y
Tumour Biol; 2016 Oct; 37(10):13871-13883. PubMed ID: 27485114
[TBL] [Abstract][Full Text] [Related]
48. The Discovery and Characterization of K-756, a Novel Wnt/β-Catenin Pathway Inhibitor Targeting Tankyrase.
Okada-Iwasaki R; Takahashi Y; Watanabe Y; Ishida H; Saito J; Nakai R; Asai A
Mol Cancer Ther; 2016 Jul; 15(7):1525-34. PubMed ID: 27196752
[TBL] [Abstract][Full Text] [Related]
49. Development of a high-throughput fluorescence polarization assay to identify novel ligands of glutamate carboxypeptidase II.
Alquicer G; Sedlák D; Byun Y; Pavlícek J; Stathis M; Rojas C; Slusher B; Pomper MG; Bartunek P; Barinka C
J Biomol Screen; 2012 Sep; 17(8):1030-40. PubMed ID: 22751730
[TBL] [Abstract][Full Text] [Related]
50. Dapper1 is a nucleocytoplasmic shuttling protein that negatively modulates Wnt signaling in the nucleus.
Gao X; Wen J; Zhang L; Li X; Ning Y; Meng A; Chen YG
J Biol Chem; 2008 Dec; 283(51):35679-88. PubMed ID: 18936100
[TBL] [Abstract][Full Text] [Related]
51. Aberrant beta-catenin and LEF1 expression may predict the clinical outcome for patients with oropharyngeal cancer.
Papagerakis P; Pannone G; Shabana AH; Depondt J; Santoro A; Ghirtis K; Berdal A; Papagerakis S
Int J Immunopathol Pharmacol; 2012; 25(1):135-46. PubMed ID: 22507326
[TBL] [Abstract][Full Text] [Related]
52. Targeting the Versatile Wnt/β-Catenin Pathway in Cancer Biology and Therapeutics: From Concept to Actionable Strategy.
Dzobo K; Thomford NE; Senthebane DA
OMICS; 2019 Nov; 23(11):517-538. PubMed ID: 31613700
[TBL] [Abstract][Full Text] [Related]
53. Lymphoid enhancer-binding factor 1, a representative of vertebrate-specific Lef1/Tcf1 sub-family, is a Wnt-beta-catenin pathway target gene in human endothelial cells which regulates matrix metalloproteinase-2 expression and promotes endothelial cell invasion.
Planutiene M; Planutis K; Holcombe RF
Vasc Cell; 2011 Dec; 3():28. PubMed ID: 22168911
[TBL] [Abstract][Full Text] [Related]
54. Interplay of Fli-I and FLAP1 for regulation of beta-catenin dependent transcription.
Lee YH; Stallcup MR
Nucleic Acids Res; 2006; 34(18):5052-9. PubMed ID: 16990252
[TBL] [Abstract][Full Text] [Related]
55. Ultra-High-Throughput Screening of Natural Product Extracts to Identify Proapoptotic Inhibitors of Bcl-2 Family Proteins.
Hassig CA; Zeng FY; Kung P; Kiankarimi M; Kim S; Diaz PW; Zhai D; Welsh K; Morshedian S; Su Y; O'Keefe B; Newman DJ; Rusman Y; Kaur H; Salomon CE; Brown SG; Baire B; Michel AR; Hoye TR; Francis S; Georg GI; Walters MA; Divlianska DB; Roth GP; Wright AE; Reed JC
J Biomol Screen; 2014 Sep; 19(8):1201-11. PubMed ID: 24870016
[TBL] [Abstract][Full Text] [Related]
56. Differentiation-inducing factor-1 alters canonical Wnt signaling and suppresses alkaline phosphatase expression in osteoblast-like cell lines.
Matsuzaki E; Takahashi-Yanaga F; Miwa Y; Hirata M; Watanabe Y; Sato N; Morimoto S; Hirofuji T; Maeda K; Sasaguri T
J Bone Miner Res; 2006 Aug; 21(8):1307-16. PubMed ID: 16869729
[TBL] [Abstract][Full Text] [Related]
57. Wnt activation and alternative promoter repression of LEF1 in colon cancer.
Li TW; Ting JH; Yokoyama NN; Bernstein A; van de Wetering M; Waterman ML
Mol Cell Biol; 2006 Jul; 26(14):5284-99. PubMed ID: 16809766
[TBL] [Abstract][Full Text] [Related]
58. E7386, a Selective Inhibitor of the Interaction between β-Catenin and CBP, Exerts Antitumor Activity in Tumor Models with Activated Canonical Wnt Signaling.
Yamada K; Hori Y; Inoue S; Yamamoto Y; Iso K; Kamiyama H; Yamaguchi A; Kimura T; Uesugi M; Ito J; Matsuki M; Nakamoto K; Harada H; Yoneda N; Takemura A; Kushida I; Wakayama N; Kubara K; Kato Y; Semba T; Yokoi A; Matsukura M; Odagami T; Iwata M; Tsuruoka A; Uenaka T; Matsui J; Matsushima T; Nomoto K; Kouji H; Owa T; Funahashi Y; Ozawa Y
Cancer Res; 2021 Feb; 81(4):1052-1062. PubMed ID: 33408116
[TBL] [Abstract][Full Text] [Related]
59. Development of a High-Throughput Fluorescence Polarization Assay to Detect Inhibitors of the FAK-Paxillin Interaction.
Marlowe T; Alvarado C; Rivera A; Lenzo F; Nott R; Bondugji D; Montoya J; Hurley A; Kaplan M; Capaldi A; Cance W
SLAS Discov; 2020 Jan; 25(1):21-32. PubMed ID: 31513463
[TBL] [Abstract][Full Text] [Related]
60. WIKI4, a novel inhibitor of tankyrase and Wnt/ß-catenin signaling.
James RG; Davidson KC; Bosch KA; Biechele TL; Robin NC; Taylor RJ; Major MB; Camp ND; Fowler K; Martins TJ; Moon RT
PLoS One; 2012; 7(12):e50457. PubMed ID: 23227175
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
